Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CYP3A7 is a member of the cytochrome P450 superfamily, primarily expressed in the fetal and neonatal liver. It functions as a monooxygenase, catalyzing the metabolism of steroid hormones like DHEA-S and testosterone, as well as certain drugs and xenobiotics. While expression declines after birth, CYP3A7 plays a crucial role in fetal development and can influence drug metabolism in neonates. Genetic variations may impact chemotherapy response in cancer patients.
Catalyzes the metabolism of steroid hormones and xenobiotics via monooxygenase activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 Family 3 Subfamily A Member 7 (CYP3A7).